We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries--an economic evaluation based on the fracture intervention trial.
- Authors
Ström, O; Borgström, F; Sen, S S; Boonen, S; Haentjens, P; Johnell, O; Kanis, J A
- Abstract
Treatment with alendronate (Fosamax) has been shown to significantly reduce the risk of fragility fractures. Cost-effectiveness of treatment was assessed in nine European countries in a Markov model and was generally found to be cost effective in women with a previous spine fracture.
- Publication
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2007, Vol 18, Issue 8, p1047
- ISSN
0937-941X
- Publication type
Journal Article
- DOI
10.1007/s00198-007-0349-5